Ideagen secures $1.6 million Q-Pulse contract in North America
Nov 23, 17
Ideagen secures $1.6 million Q-Pulse contract in North America
Ideagen today announced it has secured a $1.6 million contract win in North America.
The quality, safety, audit, performance and risk management software providers will work with a global leader in the petrochemical industry, supplying them with its flagship quality management software system Q-Pulse.
The project will involve 13 sites across the region, with around 2,500 users using the system.
David Hornsby, CEO of Ideagen, said: “We continue to see strong business demand for our software across all our key verticals. This contract demonstrates the strength of both our products and our ability to grow revenues from our extensive customer base.”
Headquartered in Nottingham, Ideagen enjoys a global presence through its operations in the United States, Europe, Middle East and Southeast Asia.
The North American contract win was awarded following the successful deployment of Ideagen’s Q-Pulse system across the petrochemical company’s other geographical locations, particularly across the Middle East.
Worth an initial $1.6 million, it is expected that 90% of the revenue, including $1.1 million of licence, will be recognised in the current financial year.
The petrochemical contract win is the latest success for Ideagen in the North American region following a number of new projects and contract extensions.
Earlier this month, RATP Dev North America announced it would implement Ideagen’s Coruson software as its safety management and incident management system as part of its new drive2zero ™ initiative. The Coruson software will be used to directly manage safety, risk and operational performance across all bus, paratransit and rail services.
Also in November, the Duke Human Vaccine Institute, a component of Duke Health, implemented Q-Pulse to assist with quality management for an HIV vaccine manufacturing programme.
Ideagen has a customer base of over 3,000 organisations using its suite of products, including many blue-chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.
For more investor-related news visit our Investor Relations section.